Utente:Minervaaa/sandbox/pag1: differenze tra le versioni

Versione delle 16:38, 8 apr 2009

Versione delle 22:39, 3 giu 2009

Riga 1:

==References==

{{reflist|2}}

==Further reading==

{{refbegin | 2}}

{{PBB_Further_reading

| citations =

*{{cite journal | author=Huang S, Houghton PJ |title=Mechanisms of resistance to rapamycins |journal=Drug Resist. Updat. |volume=4 |issue= 6 |pages= 378–91 |year= 2002 |pmid= 12030785 |doi= 10.1054/drup.2002.0227 }}

*{{cite journal | author=Harris TE, Lawrence JC |title=TOR signaling |journal=Sci. STKE |volume=2003 |issue= 212 |pages= re15 |year= 2004 |pmid= 14668532 |doi= 10.1126/stke.2122003re15 }}

*{{cite journal | author=Easton JB, Houghton PJ |title=Therapeutic potential of target of rapamycin inhibitors |journal=Expert Opin. Ther. Targets |volume=8 |issue= 6 |pages= 551–64 |year= 2005 |pmid= 15584862 |doi= 10.1517/14728222.8.6.551 }}

*{{cite journal | author=Deldicque L, Theisen D, Francaux M |title=Regulation of mTOR by amino acids and resistance exercise in skeletal muscle |journal=Eur. J. Appl. Physiol. |volume=94 |issue= 1-2 |pages= 1–10 |year= 2005 |pmid= 15702344 |doi= 10.1007/s00421-004-1255-6 }}

*{{cite journal | author=Weimbs T |title=Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? |journal=Cell Cycle |volume=5 |issue= 21 |pages= 2425–9 |year= 2007 |pmid= 17102641 |doi= }}

*{{cite journal | author=Sun SY, Fu H, Khuri FR |title=Targeting mTOR signaling for lung cancer therapy |journal=Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |volume=1 |issue= 2 |pages= 109–11 |year= 2007 |pmid= 17409838 |doi= }}

*{{cite journal | author=Abraham RT, Gibbons JJ |title=The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy |journal=Clin. Cancer Res. |volume=13 |issue= 11 |pages= 3109–14 |year= 2007 |pmid= 17545512 |doi= 10.1158/1078-0432.CCR-06-2798 }}

}}

{{refend}}